Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.

There is an increasing number of cancer patients undertaking treatment-focused genetic testing despite not having a strong family history or high a priori risk of being carriers because of the decreasing cost of genetic testing and development of new therapies. There are limited studies on the psych...

Full description

Bibliographic Details
Main Authors: Heamanthaa Padmanabhan, Nur Tiara Hassan, Siu-Wan Wong, Yong-Quan Lee, Joanna Lim, Siti Norhidayu Hasan, Cheng-Har Yip, Soo-Hwang Teo, Meow-Keong Thong, Nur Aishah Mohd Taib, Sook-Yee Yoon
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0263675
_version_ 1797867535162408960
author Heamanthaa Padmanabhan
Nur Tiara Hassan
Siu-Wan Wong
Yong-Quan Lee
Joanna Lim
Siti Norhidayu Hasan
Cheng-Har Yip
Soo-Hwang Teo
Meow-Keong Thong
Nur Aishah Mohd Taib
Sook-Yee Yoon
author_facet Heamanthaa Padmanabhan
Nur Tiara Hassan
Siu-Wan Wong
Yong-Quan Lee
Joanna Lim
Siti Norhidayu Hasan
Cheng-Har Yip
Soo-Hwang Teo
Meow-Keong Thong
Nur Aishah Mohd Taib
Sook-Yee Yoon
author_sort Heamanthaa Padmanabhan
collection DOAJ
description There is an increasing number of cancer patients undertaking treatment-focused genetic testing despite not having a strong family history or high a priori risk of being carriers because of the decreasing cost of genetic testing and development of new therapies. There are limited studies on the psychosocial outcome of a positive result among breast cancer patients who are at low a priori risk, particularly in women of Asian descent. Breast cancer patients enrolled under the Malaysian Breast Cancer Genetic Study between October 2002 and February 2018 were tested for BRCA1, BRCA2 and PALB2 genes. All 104 carriers identified were invited by a research genetic counsellor for result disclosure. Of the 104 carriers, 64% (N = 66) had low a priori risk as determined by PENN II scores. Psychosocial, risk perception and health behaviour measures survey were conducted at baseline (pre-result disclosure), and at two to six weeks after result disclosure. At baseline, younger carriers with high a priori risk had higher Cancer Worry Scale scores than those with low a priori risk but all scores were within acceptable range. Around 75% and 55% of high a priori risk carriers as well as 80% and 67% of low a priori risk carriers had problems in the "living with cancer" and "children" psychosocial domains respectively. All carriers regardless of their a priori risk demonstrated an improved risk perception that also positively influenced their intent to undergo risk management procedures. This study has shown that with sufficient counselling and support, low a priori risk carriers are able to cope psychologically, have improved perceived risk and increased intent for positive health behaviour despite having less anticipation from a family history prior to knowing their germline carrier status.
first_indexed 2024-04-09T23:42:49Z
format Article
id doaj.art-88654c5f6a94411185526c9149f4b57e
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-09T23:42:49Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-88654c5f6a94411185526c9149f4b57e2023-03-18T05:32:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01172e026367510.1371/journal.pone.0263675Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.Heamanthaa PadmanabhanNur Tiara HassanSiu-Wan WongYong-Quan LeeJoanna LimSiti Norhidayu HasanCheng-Har YipSoo-Hwang TeoMeow-Keong ThongNur Aishah Mohd TaibSook-Yee YoonThere is an increasing number of cancer patients undertaking treatment-focused genetic testing despite not having a strong family history or high a priori risk of being carriers because of the decreasing cost of genetic testing and development of new therapies. There are limited studies on the psychosocial outcome of a positive result among breast cancer patients who are at low a priori risk, particularly in women of Asian descent. Breast cancer patients enrolled under the Malaysian Breast Cancer Genetic Study between October 2002 and February 2018 were tested for BRCA1, BRCA2 and PALB2 genes. All 104 carriers identified were invited by a research genetic counsellor for result disclosure. Of the 104 carriers, 64% (N = 66) had low a priori risk as determined by PENN II scores. Psychosocial, risk perception and health behaviour measures survey were conducted at baseline (pre-result disclosure), and at two to six weeks after result disclosure. At baseline, younger carriers with high a priori risk had higher Cancer Worry Scale scores than those with low a priori risk but all scores were within acceptable range. Around 75% and 55% of high a priori risk carriers as well as 80% and 67% of low a priori risk carriers had problems in the "living with cancer" and "children" psychosocial domains respectively. All carriers regardless of their a priori risk demonstrated an improved risk perception that also positively influenced their intent to undergo risk management procedures. This study has shown that with sufficient counselling and support, low a priori risk carriers are able to cope psychologically, have improved perceived risk and increased intent for positive health behaviour despite having less anticipation from a family history prior to knowing their germline carrier status.https://doi.org/10.1371/journal.pone.0263675
spellingShingle Heamanthaa Padmanabhan
Nur Tiara Hassan
Siu-Wan Wong
Yong-Quan Lee
Joanna Lim
Siti Norhidayu Hasan
Cheng-Har Yip
Soo-Hwang Teo
Meow-Keong Thong
Nur Aishah Mohd Taib
Sook-Yee Yoon
Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.
PLoS ONE
title Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.
title_full Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.
title_fullStr Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.
title_full_unstemmed Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.
title_short Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.
title_sort psychosocial outcome and health behaviour intent of breast cancer patients with brca1 2 and palb2 pathogenic variants unselected by a priori risk
url https://doi.org/10.1371/journal.pone.0263675
work_keys_str_mv AT heamanthaapadmanabhan psychosocialoutcomeandhealthbehaviourintentofbreastcancerpatientswithbrca12andpalb2pathogenicvariantsunselectedbyaprioririsk
AT nurtiarahassan psychosocialoutcomeandhealthbehaviourintentofbreastcancerpatientswithbrca12andpalb2pathogenicvariantsunselectedbyaprioririsk
AT siuwanwong psychosocialoutcomeandhealthbehaviourintentofbreastcancerpatientswithbrca12andpalb2pathogenicvariantsunselectedbyaprioririsk
AT yongquanlee psychosocialoutcomeandhealthbehaviourintentofbreastcancerpatientswithbrca12andpalb2pathogenicvariantsunselectedbyaprioririsk
AT joannalim psychosocialoutcomeandhealthbehaviourintentofbreastcancerpatientswithbrca12andpalb2pathogenicvariantsunselectedbyaprioririsk
AT sitinorhidayuhasan psychosocialoutcomeandhealthbehaviourintentofbreastcancerpatientswithbrca12andpalb2pathogenicvariantsunselectedbyaprioririsk
AT chengharyip psychosocialoutcomeandhealthbehaviourintentofbreastcancerpatientswithbrca12andpalb2pathogenicvariantsunselectedbyaprioririsk
AT soohwangteo psychosocialoutcomeandhealthbehaviourintentofbreastcancerpatientswithbrca12andpalb2pathogenicvariantsunselectedbyaprioririsk
AT meowkeongthong psychosocialoutcomeandhealthbehaviourintentofbreastcancerpatientswithbrca12andpalb2pathogenicvariantsunselectedbyaprioririsk
AT nuraishahmohdtaib psychosocialoutcomeandhealthbehaviourintentofbreastcancerpatientswithbrca12andpalb2pathogenicvariantsunselectedbyaprioririsk
AT sookyeeyoon psychosocialoutcomeandhealthbehaviourintentofbreastcancerpatientswithbrca12andpalb2pathogenicvariantsunselectedbyaprioririsk